08:00 , Jan 22, 2015 |  BC Innovations  |  Translation in Brief

Boehringer double-dips into academia

Boehringer Ingelheim GmbH announced separate research collaborations last week in immunomodulation and cancer with two U.S. universities. A deal with Yale University focuses on identifying targets for immune modulation in cancer, autoimmune and respiratory indications,...
08:00 , Dec 15, 2011 |  BC Innovations  |  Tools & Techniques

Priming chemo prediction

Researchers at the Dana-Farber Cancer Institute have developed an in vitro assay that predicts patient response to chemotherapy by directly measuring how prone cells are to apoptosis.1Eutropics Pharmaceuticals Inc. has exclusively licensed the assay and...
07:00 , Mar 17, 2011 |  BC Innovations  |  Targets & Mechanisms

MCL1's resistance story

Separate studies by Harvard Medical School and Roche's Genentech Inc. unithave shown that increased levels of myeloid leukemia cell differentiation protein, an antiapoptotic protein in the B cell lymphoma 2 family, can enable acute lymphoblastic...